A recent study examined the incidents of acute arterial events in patients with inflammatory bowel disease, and whether IBD disease activity influenced this risk.
In a recent study, researchers investigated how a certain drug treatment affects disease outcomes and remission in patients with inflammatory bowel disease. To read the results of the study, including which...
In a recent study, researchers investigated how a certain drug treatment affects disease outcomes and remission in patients with inflammatory bowel disease. To read the results of the study, including which...
Anti-tumor necrosis factor-α (anti-TNF-α) therapy is the most prescribed biologic therapy in rheumatology and gastroenterology. However, these therapies can cause serious side effects, including new-onset...
Anti-tumor necrosis factor-α (anti-TNF-α) therapy is the most prescribed biologic therapy in rheumatology and gastroenterology. However, these therapies can cause serious side effects, including new-onset...
In this study, researchers assessed patients with inflammatory bowel disease to determine why some did not respond to anti-TNF agents or had lost response over time. To see which factors may be involved...
In this study, researchers assessed patients with inflammatory bowel disease to determine why some did not respond to anti-TNF agents or had lost response over time. To see which factors may be involved...
